alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.165 Ferrous lactate. ( a ) *Identity.* The color additive ferrous lactate is the ferrous lactate defined in § 184.1311 of this chapter.
( b ) *Specifications.* Ferrous lactate shall meet the specifications given in the Food Chemicals Codex, 4th ed. (1996), pp. 154 to 155, which is incorporated by reference in accordance with 5 U.S.C. 552(a) and 1 CFR part 51. Copies are available from the National Academy Press, 2101 Constitution Ave. NW., Washington, DC 20418, or may be examined at the Food and Drug Administration's Main Library, 10903 New Hampshire Ave., Bldg. 2, Third Floor, Silver Spring, MD 20993, 301-796-2039, or at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
( c ) *Uses and restrictions.* Ferrous lactate may be safely used in amounts consistent with good manufacturing practice for the coloring of ripe olives.
( d ) *Labeling.* The label of the color additive shall conform to the requirements of § 70.25 of this chapter.
( e ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore batches thereof are exempt from the certification requirements of section 721(c) of the Federal Food, Drug, and Cosmetic Act (the act).
[61 FR 40319, Aug. 2, 1996, as amended at 66 FR 66742, Dec. 27, 2001; 81 FR 5590, Feb. 3, 2016]
COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

I n the Matter of the Estate of Joseph

Abraham, Jr. a/k/a Joseph (Sib) Abraham,

Jr.

, Appellant

. §

§

§

§

§

§

§ No. 08

- 1 8

- 00 032

- C V

Appeal from the

Probate Court No. 1

of El Paso County, Texas

(TC# 2014CPR02054 )

O R D E R

The Appellant’s notice of appeal was filed in this office on March 1, 2018. The County

Clerk’s O ffice provided a copy of the trial court’s Order Granting Successor Dependent

Administrator’s Motion for Summary Judgment to Invalidate the Assumption Warranty Deed

Dated October 19, 2016 and Declaratory Judgment filed in the County Clerk’s O ffice on Janu ary

4, 2018. The trial court’s order reflects that it was signed on January 3, 2017, but the docketing

certificate states the order was signed on January 3, 2018. It therefore appears that the date on

which the order was signed may be incorrect.

Therefore, the Court ORDERS that the Honorable Patricia Chew , Judge for the Probate

Court No. 1 of El Paso County, Texas, determine whether the date on the order is incorrect, and if

it is, enter a corrected nunc pro tunc order including the correct year the order was signed. The

1corrected nunc pro tunc order shall be filed with the County Clerk of El Paso County, Texas, and

the County Clerk shall include said corrected order in the clerk’s record. Further, the Court on its

own motion extend s the time to file the Record until April 3, 2018

.

IT IS SO ORDERED this 5 th day of March , 2018

.

PER CURIAM

Before McClure , C.J., R odriguez and Palafox , JJ.

2
§ 500.92 Implementation. ( a ) This subpart E applies to all new animal drug applications, food additive petitions, color additive petitions, and requests for import tolerances concerning any compound intended for use in food-producing animals (including supplemental applications and amendments to petitions).
( b ) This subpart E also applies in the following manner to compounds already approved: ( 1 ) For those compounds that FDA determines may induce cancer when ingested by man or animals, i.e., suspect carcinogens, §§ 500.80(b), 500.82, and 500.90 apply.
( 2 ) For those compounds that FDA determines have been shown to induce cancer when ingested by man or animals, §§ 500.82 through 500.90 apply.
[52 FR 49586, Dec. 31, 1987, as amended at 86 FR 52410, Sept. 21, 2021]
**EXHIBIT 32.1**

**CERTIFICATION      OF PRINCIPAL EXECUTIVE OFFICER**

|                         |   |   |                                                                                                                                                                                                                                           |
|------------------------------|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                         |   |   | /s/ KEITH A. MEISTER                                                                                                                                                                                                                           |
|                              |   |   | Keith                A. Meister                                                                                                                                                                                                                |
|                         |   |   | Principal                    Executive Officer andVice                  Chairman of the Board ofAmerican Property Investors,                  Inc.,the                  General Partner ofAmerican Real Estate Partners,                  L.P. |
|                         |   |   |                                                                                                                                                                                                                                           |
| Date: November 8, 2006  |   |   |                                                                                                                                                                                                                                           |

----
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from IDS Managed
Futures II, L.P. for the third quarter of 1997 and is qualified in its entirety
by reference to such 10-Q.
</LEGEND>
<CIK> 0000813831
<NAME> IDS MANAGED FUTURES II, L.P.
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1997
<CASH>                                      12,385,526
<SECURITIES>                                         0
<RECEIVABLES>                                   40,122
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            12,425,647
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              12,425,647
<CURRENT-LIABILITIES>                          188,501
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                  12,237,146
<TOTAL-LIABILITY-AND-EQUITY>                12,425,647
<SALES>                                              0
<TOTAL-REVENUES>                             1,209,903
<CGS>                                                0
<TOTAL-COSTS>                                  308,675
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                901,228
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            901,228
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   901,228
<EPS-PRIMARY>                                    45.23
<EPS-DILUTED>                                    45.23
        

</TABLE>
#### § 133.191 Part-skim spiced cheeses.

Part-skim spiced cheeses conform to the definition and standard of identity, and are subject to the requirements for label statement of ingredients prescribed for spiced cheeses by § 133.190, except that their solids contain less than 50 percent, but not less than 20 percent, of milkfat.

[58 FR 2895, Jan. 6, 1993]
Exhibit 32.1

CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

Each of the undersigned hereby certifies, in accordance with
18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Vitran Corporation Inc., that, to his knowledge, the Annual Report of Vitran Corporation Inc. on Form 10-K for the year ended
December 31, 2010, fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and
results of operation of Vitran Corporation Inc.



|      |  |                  |  |  |  |     |  |                           
|----- |  | ---------------- |  |  |  | --- |  | --------------------------
|Date: |  | February 9, 2011 |  |  |  | By: |  | /s/ RICHARD E. GAETZ      
|      |  |                  |  |  |  |     |  | Richard E. Gaetz          
|      |  |                  |  |  |  |     |  | President and             
|      |  |                  |  |  |  |     |  | Chief Executive Officer   
|      |  |                  |  | 
|      |  |                  |  |  |  | By: |  | /s/ SEAN P. WASHCHUK      
|      |  |                  |  |  |  |     |  | Sean P. Washchuk          
|      |  |                  |  |  |  |     |  | Vice President Finance and
|      |  |                  |  |  |  |     |  | Chief Financial Officer
*Pursuant to Local Rule 47.5, the court has determined that this

opinion should not be published and is not precedent except under

the limited circumstances set forth in Local Rule 47.5.4.

UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

__________________

No. 95-30844

Summary Calendar

__________________

ANDREA HALL,

Petitioner-Appellant,

versus

BURL CAIN, Acting Warden,

Louisiana State Penitentiary,

Respondent-Appellee.

______________________________________________

Appeal from the United States District Court for the

Western District of Louisiana

(CA-94-2298)

______________________________________________

April 18, 1996

Before SMITH, BENAVIDES, and DENNIS, Circuit Judges.

PER CURIAM:*

Andrea Hall appeals from the district court's partial denial

of his 28 U.S.C. § 2254 petition for a writ of habeas corpus. A

review of the record supports the magistrate judge's finding that,

as to Hall's Louisiana conviction for the attempted second-degree

murder of Joe Lewis Atkins, Hall failed to show that his trial

attorneys' failure to challenge a defective jury instruction was
2

prejudicial. We affirm for the reasons stated by the district

court. See Hall v. Whitley, No. CV94-2298-A (W.D. La July 21,

1995).
Poly (sodium itaconate co butenoate )

Structure not shown
<PAGE>   1

                                                                    EXHIBIT 23.1




Consent of Independent Auditors

The Board of Directors
Mosaix, Inc.:

We consent to the use of our report incorporated herein by reference and to the
reference to our firm under the heading "Experts" in the prospectus.



Seattle, Washington
June 16, 1999
# C_2017121EN.01002202.xml

| 18.4.2017 | EN | Official Journal of the European Union | C 121/22 |
| --- | --- | --- | --- |

18.4.2017

EN

Official Journal of the European Union

C 121/22

---

Judgment of the General Court of 28 February 2017 — JingAo Solar and Others v Council

(Joined Cases T-158/14, T-161/14 and T-163/14) (1)

1

((Subsidies - Imports of crystalline silicon photovoltaic modules and key components (cells) originating in or consigned from China - Definitive countervailing duty - Undertakings - Action for annulment - Interest in bringing proceedings - Admissibility - Scope of the investigation - Sampling - Definition of the product concerned))

(2017/C 121/32)

Language of the case: English

Parties

Parties

Applicants: JingAo Solar Co. Ltd (Ningjin, China) and the five other applicants whose names appear in the annex to the judgment (represented initially by A. Willems, S. De Knop and J. Charles, and subsequently by A. Willems and S. De Knop, lawyers)

Applicants:

Defendant: Council of the European Union (represented by: B. Driessen, acting as Agent, B. O’Connor, Solicitor, and S. Gubel, lawyer)

Defendant:

Intervener in support of the defendant: European Commission (represented initially by J.-F. Brakeland, T. Maxian Rusche, and A. Stobiecka-Kuik, and subsequently by J.-F. Brakeland, T. Maxian Rusche, and A. Demeneix, acting as Agents)

Intervener in support of the defendant:

Re:

Re:

Application under Article 263 TFEU for the annulment of Council Implementing Regulation (EU) No 1239/2013 of 2 December 2013 imposing a definitive countervailing duty on imports of crystalline silicon photovoltaic modules and key components (i.e. cells) originating in or consigned from the People’s Republic of China (OJ 2013 L 325, p. 66), in so far as it applies to the applicants.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders JingAo Solar Co. Ltd, and the other applicants whose names appear in the annex to bear their own costs and to pay those incurred by the Council of the European Union; |
| --- | --- |

2.

Orders JingAo Solar Co. Ltd, and the other applicants whose names appear in the annex to bear their own costs and to pay those incurred by the Council of the European Union;

| 3. | Orders the European Commission to bear its own costs. |
| --- | --- |

3.

Orders the European Commission to bear its own costs.

---

(1)  OJ C 159, 26.5.2014.

1

---
Editorial Note on Part 17
Editorial Note: Nomenclature changes to part 17 appear at 68 FR 24879, May 9, 2003, and at 88 FR 45065, July 14, 2023.

§ 17.30 Computation of time. ( a ) In computing any period of time under this part or in an order issued thereunder, the time begins with the day following the act or event, and includes the last day of the period, unless either such day is a Saturday, Sunday, or Federal holiday, in which event the time includes the next business day.
( b ) When the period of time allowed is less than 7 days, intermediate Saturdays, Sundays, and Federal holidays shall be excluded from the computation.
( c ) When a document has been served or issued by placing it in the mail, an additional 5 days will be added to the time permitted for any response.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of General Medical Sciences Special Emphasis Panel, Consortia for High-Throughput-Enabled Structural Biology Partnerships (U01).                    

*Date:*                         April 1-2, 2010.                    

*Time:*                         8:30 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Regency Bethesda,  One Bethesda Metro Center,  7400 Wisconsin Avenue,  Bethesda, MD 20814.                    

*Contact Person:*                         Margaret J. Weidman, PhD,  Scientific Review Officer,  Office of Scientific Review,  National Institute of General Medical Sciences,  National Institutes of Health,  45 Center Drive, Room 3AN18B,  Bethesda, MD 20892,  301-594-3663.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority  Initiatives, National Institutes of Health, HHS)

Dated: February 25, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-4484 Filed 3-3-10; 8:45 am]

BILLING CODE 4140-01-P
[Federal Register Volume 75, Number 40 (Tuesday, March 2, 2010)]
[Notices]
[Page 9398]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4029]


-----------------------------------------------------------------------

CONSUMER PRODUCT SAFETY COMMISSION


Sunshine Act Meetings

Time and Date: Wednesday, March 3, 2010, 9 a.m.-12 Noon.

Place: Hearing Room 420, Bethesda Towers, 4330 East-West Highway, 
Bethesda, Maryland.

Status: Commission Meeting--Open to the Public.

MATTERS TO BE CONSIDERED: 

1. Civil Penalty Factors--Final Rule

    A live webcast of the Meeting can be viewed at http://www,cpsc.gov/webcast/index.html.
    For a recorded message containing the latest agenda information, 
call (301) 504-7948.

CONTACT PERSON FOR MORE INFORMATION:  Todd A. Stevenson, Office of the 
Secretary, U.S. Consumer Product Safety Commission, 4330 East-West 
Highway, Bethesda, MD 20814, (301) 504-7923.

    Dated: February 22, 2010.
Todd A. Stevenson,
Secretary.
[FR Doc. 2010-4029 Filed 3-1-10; 8:45 am]
BILLING CODE 6355-01-M
1Hunt, JeffFrom:Hunt, JeffSent:Friday, December 27, 2013 10:47 AMTo:Robert UkeileyCc:Fidis, Alexander; Hunt, JeffSubject:RE: EPA-R10-OAR-2013-071, Washington PM10 maintenance planDearMr.Ukeiley,Tothebestofmyknowledge,theRegulations.govsystemdoesnotallowmetodoafinaluploadofsupportingdocumentsuntilaftertheFederalRegisterpublishes.Oursystemalsogivesawarningthatitcansometimestakeupto24hoursformaterialstoposttothepublicwebsiteafterIhitthefinal“submit”button.Whyourgovernmentcomputersystemissounbelievablyclunkyisanissuebeyondmycontrol.Thatsaid,Icheckedthepublicregulations.govsiteandallmaterialsareposted:http://www.regulations.gov/#!docketDetail;D=EPA‐R10‐OAR‐2013‐0713Ifyoufeellikeourcomputersystemhascreatedanundoburdenonyou,youarewelcometosubmityourcommentsdirectlytomeusingtheR10-Public_Comments@epa.gove‐mailaddressonJanuary28ratherthanthe27th.FeelfreetocontactmeorourRegionalCounselAlexFidisat206‐553‐4710ifyouhaveanyfurtherquestionsorconcerns.Thanks.......jhFrom:Robert Ukeiley [mailto:rukeiley@igc.org]Sent:Thursday, December 26, 2013 12:43 PMTo:Hunt, JeffSubject:EPA-R10-OAR-2013-071, Washington PM10 maintenance planDear Mr. Hunt:I am writing to comment on the above referenced proposed rule.It appears that EPA failed to put any of the supporting documents for EPA–R10–OAR–2013–0713, Approval and Promulgation ofImplementation Plans; Washington: Kent, Seattle, and Tacoma Second 10-Year PM LimitedMaintenance Plan , in the docket on Regulations.gov.All I can find is the proposed rule.If you think the supporting documents are actually currently on the regulations.gov web page, please let me know. If you havenot placed thedocuments on the web page, I am requesting that you put all ofthe supporting documents in the docket on Regulations.gov and extend the publiccomment period to at least 30 days after you provide the supporting documents.2Please let me know when you have done this.Sincerely,RobertUkeileyLawOfficeofRobertUkeiley507CenterStreetBerea,KY40403Tel:859‐986‐5402rukeiley@igc.orgCounselforSierraClub
##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 FORM 10-KSB/A
 (Amendment No. 1)
 Annual Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 For the fiscal year ended December 31, 2007
    
    Commission file No. 0-26206
 Orthometrix, Inc.
  Delaware
    
    06-1387931(State or other jurisdiction of incorporation or 
organization)
    
    (I.R.S. Employer Identification No.)106 Corporate Park Drive, Suite 102, White 
Plains, NY
    
    10604(Address of principal executive office)
    
    (Zip Code)
 (914) 694-2285
  None
  Common Stock, par value $0.0005 per share
 þ o
 o
  o þ
    Documents Incorporated By Reference
  o þ




---



##### 



TABLE OF CONTENTS
  PART IIIITEM 8A. CONTROLS AND PROCEDURESITEM 8B. OTHER INFORMATIONSIGNATURESEX  31.1 (EXHIBIT 31.1)EX  32.1 (EXHIBIT 32.1)EX  32 (EXHIBIT 32)EX-31.1: CERTIFICATIONEX-31.2: CERTIFICATIONEX-32: CERTIFICATION




---



##### Table of Contents



EXPLANATORY NOTE
    -1-




---



##### Table of Contents



PART III
 
 ITEM 8A.
    
    CONTROLS AND PROCEDURES
 Disclosure Controls and Procedures
  Managements Report on Internal Control over Financial Reporting
   1.
    
    pertain to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of our assets;2.
    
    provide reasonable assurance that transactions are recorded as necessary
to permit preparation of consolidated financial statements in accordance with
generally accepted accounting principles, and that our receipts and expenditures are
being made only in accordance with authorizations of our management and directors;
and3.
    
    provide reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of our assets that could have a
material effect on the consolidated financial statements.
  Internal
Control over Financial Reporting  Guidance for Smaller Public Companies
 -2-




---



##### Table of Contents



Changes in Internal Controls
   
 ITEM 8B.
    
    OTHER INFORMATION
  -3-




---



##### Table of Contents



SIGNATURES
 th
 ORTHOMETRIX, INC.By:
    /s/ Reynald BonmatiName:
    Reynald G. BonmatiTitle:
    President
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

HUGH MESSEC, a/k/a JOE R. HOPKINS,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

No. 4D18-2370

[July 18, 2019]

Appeal from the Circuit Court for the Seventeenth Judicial Circuit, 

Broward County; Barbara McCarthy, Judge; L.T. Case No. 91-7274CF10A.

Joe R. Hopkins, Raiford, pro se.

Ashley Moody, Attorney General, Tallahassee, and Jeanine 

Germanowicz, Assistant Attorney General, West Palm Beach, for appellee.

PER CURIAM.

Affirmed.

WARNER, DAMOORGIAN and CIKLIN, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.